Which of the following complement components attaches to the crystallizable fragment of immunoglobulin M ?
**Core Concept**
The complement system is a group of proteins that help eliminate pathogens from the body by marking them for destruction and facilitating their removal. The classical pathway of the complement system is initiated by the binding of the first component, C1, to the Fc region of immunoglobulins, specifically IgM and IgG.
**Why the Correct Answer is Right**
The correct answer is C1qrs, which is the first component of the classical pathway of the complement system. C1qrs binds to the Fc region of IgM through its C1q subunit, which recognizes the crystallizable fragment (Fc) of the immunoglobulin. This interaction triggers the activation of C1r and C1s, leading to the cleavage of C4 and C2, and the formation of C4b2a, also known as C3 convertase. The binding of C1qrs to IgM is a crucial step in the activation of the classical pathway and the subsequent elimination of pathogens.
**Why Each Wrong Option is Incorrect**
**Option A:** C5b is involved in the formation of the membrane attack complex (MAC), which forms pores in the membrane of target cells, leading to their lysis. It does not attach to the Fc region of IgM.
**Option B:** C5a is an anaphylatoxin that is generated during the activation of C5 and plays a role in inflammation and chemotaxis. It does not attach to the Fc region of IgM.
**Option D:** C4b2a is the C3 convertase of the classical pathway, formed by the cleavage of C4 and C2. It does not attach to the Fc region of IgM but rather is generated as a result of the interaction between C1qrs and IgM.
**Clinical Pearl / High-Yield Fact**
It is worth noting that the classical pathway of the complement system is activated by the binding of C1qrs to the Fc region of IgM and IgG, but it is less efficient than the alternative pathway, which is activated by the binding of C3b to surfaces. Understanding the different pathways of the complement system is crucial for appreciating the mechanisms of immune defense and the development of therapeutic strategies to modulate the complement system in disease.
✓ Correct Answer: C. C1qrs